Skip to content

The role of TREM2 in cognitive dysfunction after hip replacement in elderly patients and the correlation between preoperative exercise and soluble TREM2 content in cerebrospinal fluid

The role of TREM2 in cognitive dysfunction after hip replacement in elderly patients and the correlation between preoperative exercise and soluble TREM2 content in cerebrospinal fluid

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088142
Enrollment
Unknown
Registered
2024-08-12
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip replacement surgery patients in the elderly

Interventions

The POCD and non-POCD groups:NA

Sponsors

Longyan First Hospital, Fujian Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria:   This study was reviewed by the China Clinical Trials Registry and approved by the ethics committee of the Longyan First Hospital School, and all patients gave informed consent.80 elective patients with unilateral total hip arthroplasty at Longyan First Hospital between July, 2024, and July, 2025, who were non-women, aged 60-85 years, weighed 50-80 kg, had ASA class I-III, and underwent anesthesia with subarachnoid-epidural joint block were selected.

Exclusion criteria

Exclusion criteria: 1. preoperative Mini-Mental State Scale (MMSE) score <24 2. history of severe neurological or psychiatric disorders such as Alzheimer's disease, Parkinson's syndrome, cerebrovascular accidents, etc. 3. drug or substance abuse with long-term steroids or hormones 4. preoperative combined stage III-IV hepatic encephalopathy 5. recent history of major surgery 6. severe visual and hearing impairment 7. preoperative coagulopathy, contraindicated by subarachnoid-epidural joint blockade 8. patients or family unable to cooperate; 9. Patients with difficulty in puncture and repeated punctures; 10. There is infection, damage, etc. at the puncture site.

Design outcomes

Primary

MeasureTime frame
Triggering receptor expressed on myeloid cells 2 in CSF;Triggering receptor expressed on myeloid cells 2 in plasma2;

Secondary

MeasureTime frame
TNF-a;INF-?;IL-1ß;TGF-ß;IL-4;IL-10;

Countries

China

Contacts

Public ContactJian Chunfang

Longyan First Hospital, Fujian Province

862304000@qq.com+86 182 5047 7608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026